BIO

Bio-Rad Laboratories, Inc.Class A
Data: 2026-09-11
$371.19
Price
0.66%
Change
$396.23
52W High
$236.73
52W Low
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Sep 11, 2026

44.0

AI Score

HOLD

0.67

Volume Ratio

Nov 04, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

BIO Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

BIO Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

BIO Options - Sort by Max open Interest (near term)

11th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BIO Daily Out of Money Options - Sort by Max open Interest (near term)

11th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BIO Daily In the Money Options - Sort by Max open Interest (near term)

11th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BIO Most Active Options by Volume(near term)

11th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track
BIO Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BIO Stock Summary

Last updated Sep 11, 2026

BIO is currently trading at $371.19, positioned above its 200-day moving average of $303.32, indicating a long-term uptrend. The stock has a 52-week range of $236.73 to $396.23.

Technical Analysis: The 50-day moving average stands at $342.41, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 53.721, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.015, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BIO at 44.0/100 with a HOLD recommendation.

BIO (Bio-Rad Laboratories, Inc.Class A) Indicators

Last updated Sep 11, 2026

Indicator Value
RSI(14) 53.721
CMF (20) -0.015
ROC (10) -4.544
ADX (14) 47.503
Indicator Value
MACD (12,26,9) 9.37
AROONOSC (14) -64.286
WILLAMS %R (14) -86.773
MFI (14) 53.425

BIO Candlestick Patterns

Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.

Date Pattern Signal 5-Day Hit Rate Edge vs Baseline Sample
Sep 08 Marubozu (bearish) (contrarian — textbook says the opposite) Bullish 56.2% +3.2 pts 30540
Sep 01 Marubozu (bearish) (contrarian — textbook says the opposite) Bullish 56.2% +3.2 pts 30540

These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.

Bio-Rad Laboratories, Inc.Class A is above both the 50 Day and 200 Day SMA which is considered Bullish.

BIO Moving Averages Analysis

Bio-Rad Laboratories, Inc.Class A has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 11, 2026

Bio-Rad Laboratories, Inc.Class A has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 11, 2026

BIO (Bio-Rad Laboratories, Inc.Class A) Simple Moving Averages

Moving Averages are last updated Sep 11, 2026

Days MA
10 381.43
20 377.5
30 367.33
50 342.41
100 312.8
200 303.32

BIO Fundamental Analysis

P/E (Forward) 41.4938
P/E (Trailing) 45.916
Market Cap ($) 10.1 billion
Earnings/Share ($) 8.21
Net Profit Margin (%) 0.0859
Dividend/Share ($) --
EPS Estimate Current Year ($) 9.4831
EPS Estimate Next Year ($) 10.028
WallStreet Target Price ($) 329.00
Most Recent Quarter

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.